Barinthus Biotherapeutics (BRNS) Common Equity (2020 - 2026)
Barinthus Biotherapeutics (BRNS) reported Common Equity of $57.13 million for Q2 2026, down 44.2% from $102.48 million a year earlier and down 14.1% from the prior quarter.
Powered by 
Analysis
Barinthus Biotherapeutics (BRNS) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Barinthus Biotherapeutics posted Common Equity of $74.29 million, down 42.9% from FY2024.
- Common Equity has declined for four consecutive years.
- By year, Common Equity came in at $130.14 million in FY2024 (-30.4%), $187 million in FY2023 (-23.1%), $243.2 million in FY2022 (-3.7%) and $252.56 million in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Common Equity since Q1 2021.
- Year over year, Common Equity has now declined in each of the last 15 quarters, with an average decline of 36.6% over the last eight quarters.
- The high point for year-over-year Common Equity in five years was Q2 2022 (growth of 1.9%); the low point was Q3 2025 (a decline of 47.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $66.48 million (Q1 2026), $74.29 million (Q4 2025) and $84.56 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Barinthus Biotherapeutics | 30.23 Mn | 30.29 Mn | - | 57.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 57.13 Mn |
| Mar 31, 2026 | 66.48 Mn |
| Dec 31, 2025 | 74.29 Mn |
| Sep 30, 2025 | 84.56 Mn |
| Jun 30, 2025 | 102.48 Mn |
| Mar 31, 2025 | 115.59 Mn |
| Dec 31, 2024 | 130.14 Mn |
| Sep 30, 2024 | 159.46 Mn |
| Jun 30, 2024 | 156.79 Mn |
| Mar 31, 2024 | 172.02 Mn |
| Dec 31, 2023 | 187.00 Mn |
| Sep 30, 2023 | 195.60 Mn |
| Jun 30, 2023 | 217.46 Mn |
| Mar 31, 2023 | 233.57 Mn |
| Dec 31, 2022 | 243.20 Mn |
| Sep 30, 2022 | 244.15 Mn |
| Jun 30, 2022 | 254.77 Mn |
| Mar 31, 2022 | 253.14 Mn |
| Dec 31, 2021 | 252.56 Mn |
| Sep 30, 2021 | 242.47 Mn |
API Access
Barinthus Biotherapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=BRNS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "BRNS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=BRNS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();